Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 145, 112437
Abstract
No abstract availableKeywords
Funding Information
- China Medical University, Taiwan
- Chang Bing Show Chwan Memorial Hospital (BRD-108029)
- Ministry of Education
- China Medical University Hospital (DNR-110-071)
- China Medical University (CMUIACUC-2020-021)
- Ministry of Science and Technology, Taiwan (MOST 109-2314-B-039-021-MY3)
This publication has 43 references indexed in Scilit:
- Modulation of the Tumor Metastatic Microenvironment and Multiple Signal Pathways byPrunella vulgarisin Human Hepatocellular CarcinomaThe American Journal of Chinese Medicine, 2016
- Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signalingInternational Journal of Oncology, 2014
- Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cellsBiological Research, 2014
- A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK‐Hep1 cells through the inhibitions of NF‐kB and matrix metalloproteinase‐2/‐9‐signaling pathwaysEnvironmental Toxicology, 2013
- Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinomaEuropean Journal of Clinical Investigation, 2012
- NF-κB and STAT3 – key players in liver inflammation and cancerCell Research, 2010
- NF-κB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapyCancer Letters, 2009
- Evaluation of Nuclear Factor-κB, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular CarcinomaClinical Cancer Research, 2004
- Induction of cIAP-2 in Human Colon Cancer Cells through PKCδ/NF-κBJournal of Biological Chemistry, 2003